top of page

TARGETED THERAPIES

  • Targeted therapies have an outstanding benefit-to-risk ratio on various diseases compared to non-specific therapies

  • Modern immunology offers new ways of treating cancers with vaccines 
     

  • Oncolytic viruses are the potent anti-cancer agents with the first product on the market T-VEC (Amgen)

THERAPEUTIC AREAS

  • Various cancer types

  • Autoimmune disease

  • Rare genetic diseases

  • Neurology

Invest_europe.png
4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764)

4BIO Partners LLP is an SEC Registered Investment Advisor number 801-121342
© 2015-2024 by 4BIO Partners LLP
bottom of page